Le Lézard
Classified in: Health
Subjects: PDT, MAT

Boston Hemp Inc: Releasing New Cannabinoids, Expanding the Industry


BOSTON, May 17, 2022 /PRNewswire/ -- With new cannabinoids being discovered constantly within the hemp industry, the market continues to expand its offerings rapidly. Boston Hemp Inc. is one of the largest wholesalers in the United States and is introducing customers to new cutting-edge natural alternatives as quickly as they are produced.

With the marijuana industry's recent struggles and high prices, many customers are turning to hemp alternatives to replace their daily intake of THC. What cannabinoids are they turning to? Boston Hemp has been on the forefront of releasing the latest cannabinoids to be discovered. With the recent popularity of Delta-8 THC, lesser-known cannabinoids such as THC-O, HHC, and even hemp-derived Delta-9 THC, which are all federally legal, provide new options for customers looking to explore the depths of what hemp has to offer. "Delta-8 is a great alternative, but our customer base is finding a unique pleasure in ordering HHC (hexahydrocannabinol), THC-O, CBD, and hemp derived Delta-9 gummies" said Brandon Gadles, CEO at Boston Hemp Inc. "The prices are extremely affordable, and every product is 100% insured and lab tested for potency" he added.

HHC is a hydrogenated derivative of Delta-9 THC. THC-O is derived from Delta-8 THC. Legal Delta-9 THC is derived from hemp, but still contains a total level less than 0.3% by dry weight in each product. These newly released cannabinoids for the market are what customers expect to see from Boston Hemp and other industry leaders providing the newest options available.

The (what seems to be never ending) release of cannabinoids extracted from the hemp plant has catapulted the industry's growth globally at a remarkable rate. The hemp market size was valued at $4.9 billion in 2019 but is now projected to reach $18.6 billion by 2027, registering a CAGR of 22.4% from 2021 to 2027. Market researchers believe this growth can be directly attributed to innovative companies like Boston Hemp Inc. introducing the new cannabinoids.  

As more cannabinoids continue to be discovered and produced for the market, testing the products is of the upmost importance. All of Boston Hemp's products are 100% insured and lab tested by third-party labs, ensuring accuracy and potency. The entire catalog of products, as well as wholesale requests, can be found on the company's website at bostonhempinc.com.

SOURCE Boston Hemp Inc.


These press releases may also interest you

at 05:50
CN Bio, a leading provider of single- and multi-organ microphysiological systems, today announced it has raised a $21 million investment in the first close of its Series B fundraising round. The funding has been secured from several new investors;...

at 05:05
Crucial Data Solutions (CDS), a leading provider of data collection and trial management software to advance clinical research, today announced the launch of TrialKit PACS. This innovative solution streamlines medical image management within clinical...

at 05:05
SOPHiA GENETICS , a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Nigeria-based Syndicate Bio has signed on to implement MSK-ACCESS® powered with SOPHiA DDMtm. Syndicate Bio is the...

at 05:00
Bringing order to chaos is a challenge in the best of circumstances. "We support the Ukrainian people in their fight for freedom in a...

at 04:00
Today Benchling announced that Zealand Pharma A/S, ("Zealand") a biotechnology company focused on the discovery and development of peptide-based medicines, has selected the Benchling R&D Cloud as its central source of truth for scientific data,...

at 03:38
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today an update from a Type C meeting with the FDA, regarding the company's plans for a global...



News published on and distributed by: